Focus Partners Advisor Solutions’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Focus Partners Advisor Solutions’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$245K	Sell	2,065 -12	-0.6%	-$1.3K	﹤0.01%	1099
2026 Q1	$216K	Buy	2,077 +1	+0%	+$106	﹤0.01%	1127
2025 Q4	$217K	Buy	+2,076	New	+$209K	﹤0.01%	999
2025 Q2	–	Sell	-2,401	Closed	-$208K	–	1154
2025 Q1	$208K	Buy	+2,401	New	+$205K	﹤0.01%	900

Other funds holding PJP

PAM

Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

MML Investors Services Springfield, Massachusetts $49B AUM 25.55% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

JGCM

Joseph Group Capital Management Columbus, Ohio $476M AUM 21.21% 1-Year Est. Return

Focus Partners Advisor Solutions's PJP Position: Q2 2026 in Review

Focus Partners Advisor Solutions reduced its Invesco Pharmaceuticals ETF (PJP) stake by 0.58% in Q2 2026, selling an estimated $1.3K and leaving 2,065 shares worth $245K. The position accounts for ﹤0.01% of the portfolio, ranked #1099.

Focus Partners Advisor Solutions first reported a position in PJP in Q1 2025 and has held it in 4 quarters since. 116 funds tracked by Wall St. Rank hold PJP as of Q2 2026.

Focus Partners Advisor Solutions held 2,065 shares of Invesco Pharmaceuticals ETF worth $245K as of Q2 2026.
Focus Partners Advisor Solutions sold 12 Invesco Pharmaceuticals ETF shares in Q2 2026, an estimated $1.3K.
Invesco Pharmaceuticals ETF made up ﹤0.01% of Focus Partners Advisor Solutions's portfolio in Q2 2026, its #1099 holding.
Focus Partners Advisor Solutions first reported a position in Invesco Pharmaceuticals ETF in Q1 2025 and has held it in 4 quarters since.
116 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2026.

Based on Focus Partners Advisor Solutions's 13F filing for Q2 2026, filed 6 Aug 2026.